Home › Kidney Cancer (Renal Cell Carcinoma) › Ohio › Parma
Kidney Cancer (Renal Cell Carcinoma) clinical trials in Parma, OH
3 studies for Kidney Cancer (Renal Cell Carcinoma) are looking for participants at sites in and around Parma (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
RecruitingPhase 2
- University Hospitals Parma Medical Center, Parma
- UH Seidman Cancer Center at UH Avon Health Center, Avon · 17 mi away
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
RecruitingPhase 3
- UH Seidman Cancer Center at UH Avon Health Center, Avon · 17 mi away
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
RecruitingPhase 3
- UH Seidman Cancer Center at UH Avon Health Center, Avon · 17 mi away
Kidney Cancer (Renal Cell Carcinoma) trials in other cities
- Houston, TX35 studies
- New York City, NY27 studies
- Nashville, TN23 studies
- Dallas, TX23 studies
- St. Louis, MO23 studies
- Los Angeles, CA20 studies
- Boston, MA16 studies
- Baldwin Park, CA16 studies
- Pittsburgh, PA15 studies
- Philadelphia, PA15 studies
- Queens, NY15 studies
- Cleveland, OH14 studies
Other studies in Parma
- Ulcerative Colitis10 studies
- Crohn's Disease8 studies
- Steatotic Liver Disease7 studies
- Psoriatic Arthritis6 studies
- Schizophrenia5 studies
- Major Depressive Disorder5 studies
- Lung Cancer5 studies
- Alzheimer's Disease4 studies
- Psychotic Disorders4 studies
- Inflammatory Bowel Disease4 studies
- Ovarian Cancer4 studies
- Endometrial Cancer4 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.